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Fig. S1. APOE genotype does not impact levels of sortilin or FABP7 in primary astrocytes 
(A) Immunodetection of FABP7 (red) and sortilin (green) in primary astrocytes from apoE3 
mice either (WT) or genetically deficient for Sort1 (KO). FAPB7-stained cells are identified as 
astrocytes by expression of GFAP (blue). Merged images show co-expression of FABP7 and 
sortilin. Images represent single z-planes. Scale bar: 20 µm. (B) Exemplary western blot 
analyses of sortilin, FABP5, and FABP7 in primary astrocytes from apoE3 or apoE4 targeted 
replacement mice, either wild-type (WT) or homozygous for the Sort1 null allele (KO). 
Detection of GAPDH served as loading control. (C - D) Quantitative analysis of FABP7 (C) and 
sortilin (D) levels in primary astrocyte cultures using densitometric scanning of replicate blots 
(as exemplified in panel B). No genotype-dependent alterations in FABP7 or sortilin levels were 
seen comparing cells of the indicated APOE and Sort1 genotypes. Data are given as mean ± 
SEM with E3/WT levels set to 100% (n=9 independent cultures per genotype). (E) Levels of 
Fabp7 transcript were identical in primary astrocytes from apoE3- and apoE4-expressing mice, 
either WT or KO for Sort1, as determined by quantitative RT-PCR (n=5 independent cultures 
per genotype). Values are given as log2 fold change relative to the respective WT (set to 
value 0).

























Table S1. List of selected proteins with altered cell surface localization in primary 
cultures of sortilin-deficient neurons or astrocytes 
ACC Protein Gene ratio (KO/WT) p-value 
Neurons 
P15209 BDNF/NT-3 growth factors receptor Trkb 0.724 0.020768 
Q01279 Epidermal growth factor receptor Egfr 0.793 0.000107 
Q04519 Sphingomyelin phosphodiesterase Asmase 1.53 0.005667 
Q8C0E2 Vacuolar protein sorting-associated protein 26B Vps26b 1.56 0.0035004 
P51880 Fatty acid-binding protein, brain (FABP7) Fabp7 1.52 0.033944 
P11404 Fatty acid-binding protein, heart (FABP3) Fabp3 1.4 0.22835 
Q05816 Fatty acid-binding protein, epidermal (FABP5) Fabp5 1.25 0.11495 
Astrocytes 
P15209 BDNF/NT-3 growth factors receptor Trkb 0.774 0.03436 
P28798 Progranulin Grn 0.646 0.000474 
Q06335 Amyloid-like protein 2 Aplp2 0.707 0.000877 
P41233 ATP-binding cassette transporter ABCA1 Abca1 0.756 0.003095 
P51880 Fatty acid-binding protein, brain (FABP7) Fabp7 0.94 0.61984 
P11404 Fatty acid-binding protein, heart (FABP3) Fabp3 not detected 
Q05816 Fatty acid-binding protein, epidermal (FABP5) Fabp5 not detected 
ACC, Uniprot accession number; ratio (KO/WT), ratio between protein amounts in cell 
surface fractions from sortilin KO and WT primary cell cultures as determined by 
quantitative label-free proteomics; p-value is given based on a resampling ANOVA-based 
significance test. 

























Table S2. Patient samples examined by western blot analysis. Specimens were 
obtained from the Netherlands Brain Bank (NL; Netherlands Institute for Neuroscience, 
Amsterdam) and the MRC London Brain Bank for Neurodegenerative Diseases (UK; Institute 
of Psychiatry, King's College London). 








94-110 82 F AD dementia VI 4/4 NL 
94-037 63 M AD dementia VI 4/4 NL 
94-082 64 M AD dementia VI 4/4 NL 
98-060 66 M AD dementia VI 4/4 NL 
94-091 83 F AD dementia VI 3/3 NL 
94-025 85 F AD dementia VI 3/3 NL 
94-016 86 F AD dementia VI 3/3 NL 
93-140 87 F AD dementia IV 3/3 NL 
97-009 89 F AD dementia VI 3/3 NL 
92-022 91 F AD dementia IV 3/3 NL 
93-011 92 F AD dementia VI 3/3 NL 
99-114 92 F AD dementia IV 3/3 NL 
99-123 93 F AD dementia IV 3/3 NL 
96-020 58 M AD dementia VI 3/3 NL 
94-028 70 M AD dementia VI 3/3 NL 
95-077 72 M AD dementia VI 3/3 NL 
90-066 89 M AD dementia IV 3/3 NL 
92-024 89 M AD dementia IV 3/3 NL 
99-064 89 M AD dementia VI 3/3 NL 
A197/88 81 M AD dementia V-VI 3/3 UK 
A005/96 89 M AD dementia - 3/3 UK 
A012/96 89 M AD dementia V-VI 3/3 UK 
A013/96 85 M AD dementia V-VI 3/3 UK 
A342/96 67 M AD dementia V-VI 3/3 UK 
A277/97 89 M AD dementia V-VI 3/3 UK 
A065/02 82 M AD dementia V-VI 3/3 UK 
A093/97 91 M AD dementia V-VI 4/4 UK 
A200/97 74 M AD dementia - 4/4 UK 
A213/94 81 F AD dementia III-IV 3/3 UK 
A335/94 72 F AD dementia V-VI 3/3 UK 
A125/95 88 F AD dementia V-VI 3/3 UK 
A044/96 84 F AD dementia V-VI 3/3 UK 
A097/96 90 F AD dementia V-VI 3/3 UK 
A291/96 60 F AD dementia V-VI 3/3 UK 
A407/96 75 F AD dementia V-VI 3/3 UK 
A025/97 80 F AD dementia V-VI 3/3 UK 

























A026/98 80 F AD dementia V-VI 3/3 UK 
A028/98 70 F AD dementia V-VI 3/3 UK 
A207/98 91 F AD dementia V-VI 3/3 UK 
A133/99 92 F AD dementia III-IV 3/3 UK 
A053/95 76 F AD dementia V-VI 4/4 UK 
A240/95 75 F AD dementia V-VI 4/4 UK 
A366/95 79 F AD dementia V-VI 4/4 UK 
A073/96 89 F AD dementia V-VI 4/4 UK 
A133/97 92 F AD dementia - 4/4 UK 
A053/98 89 F AD dementia V-VI 4/4 UK 
Table S3. Patients examined by immunohistology 
Case 















1 71 M 12 
AD 
dementia 4 V-VI 3 A3, B3, C3 
2 75 M 6 
AD 
dementia 4 V-VI 2 A3, B3, C2 
3 82 F 24 
AD 
dementia 4 V-VI 3 A3, B3, C3 
Neuropathological assessments: All cases were extensively characterized according to the 
routine protocol for neurodegenerative diseases. Neuropathological diagnosis of AD was made 
following the NIA-AA criteria including Thal phasing for Aβ load, Braak-and- Braak-staging 
for NFTs, and CERAD neuritic plaque score to assess the density of neuritic plaques. (Clin 
Pathol. 2019 Nov;72(11):725-735;. Neuropathology of Neurodegenerative Diseases. (2014). In 
G. Kovacs (Ed.), Neuropathology of Neurodegenerative Diseases: A Practical Guide (pp. I-Ii). 
Cambridge: Cambridge University Press). 
Table S4. Neurons 
The complete data set of proteins identified in the surface proteome of wild-type and sortilin-
deficient primary neurons is provided as an Excel file. 
Table S5. Astrocytes 
The complete data set of proteins identified in the surface proteome of wild-type and sortilin-
deficient primary astrocytes is provided as an Excel file. 
Click here to download Table S4
Click here to download Table S5
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